SCHEMBL28599435

SCHEMBL28599435

CO[Si](C)(Cc1nc2c(OCc3ccccc3)ncnc2n1C1CCCCO1)C(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DAPK1 P53355 3/20 0.43
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ SLC29A1 Q99808 2/20 0.35
▸ MAP4K1 Q92918 4/20 0.35
▸ TSHR P16473 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ ATR Q13535 1/20 0.34
▸ HSPA5 P11021 1/20 0.33
▸ PIK3CD O00329 1/20 0.32
▸ YTHDC1 Q96MU7 1/20 0.31
▸ GALR3 O60755 1/20 0.31
▸ NR2F2 P24468 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28578067 0.87 NPC1 (0.40) NPC1RAB9ASMN1; SMN2SLC29A1MAP4K1
SCHEMBL21685694 0.86 DAPK1 (0.44) DAPK1NPC1RAB9ASMN1; SMN2SLC29A1
SCHEMBL21685270 0.84 NPC1 (0.46) DAPK1NPC1RAB9ASMN1; SMN2SLC29A1
SCHEMBL28593390 0.82 SMN1; SMN2 (0.42) DAPK1NPC1RAB9ASMN1; SMN2SLC29A1
SCHEMBL21685593 0.81 NPC1 (0.42) DAPK1NPC1RAB9ASMN1; SMN2SLC29A1
SCHEMBL28593391 0.76 NPC1 (0.42) DAPK1NPC1RAB9ASMN1; SMN2SLC29A1
SCHEMBL21684878 0.74 NPC1 (0.41) DAPK1NPC1RAB9ASMN1; SMN2SLC29A1
SCHEMBL21685668 0.73 MAP4K1 (0.42) DAPK1NPC1RAB9ASMN1; SMN2SLC29A1
SCHEMBL21685038 0.69 NPC1 (0.41) NPC1RAB9ASMN1; SMN2MAP4K1TSHR
SCHEMBL21685477 0.69 NPC1 (0.46) NPC1RAB9ASMN1; SMN2SLC29A1MAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112789040-A Transglutaminase 2(TG2) inhibitors 思达利医药公司 2021-05-11 — — CN disclosed
Send feedback